In vivo treatment with the casein kinase 2 inhibitor 4, 5, 6, 7‐tetrabromotriazole augments the slow afterhyperpolarizing potential and prevents acute epileptiform activity. Issue 1 (6th December 2013)
- Record Type:
- Journal Article
- Title:
- In vivo treatment with the casein kinase 2 inhibitor 4, 5, 6, 7‐tetrabromotriazole augments the slow afterhyperpolarizing potential and prevents acute epileptiform activity. Issue 1 (6th December 2013)
- Main Title:
- In vivo treatment with the casein kinase 2 inhibitor 4, 5, 6, 7‐tetrabromotriazole augments the slow afterhyperpolarizing potential and prevents acute epileptiform activity
- Authors:
- Brehme, Hannes
Kirschstein, Timo
Schulz, Robert
Köhling, Rüdiger - Abstract:
- <abstract abstract-type="main" id="epi12474-abs-0001"> <title>Summary</title> <sec id="epi12474-sec-0001" sec-type="section"> <title>Objective</title> <p>The slow afterhyperpolarizing potential (sAHP) following prolonged depolarization is a major intrinsic mechanism of neuronal inhibition, by powerfully dampening excitability for up to 2 s. Therefore, an altered sAHP function might be vulnerable to hyperexcitable states such as epilepsy. Here, we have investigated the role of casein kinase 2 (CK2) on the sAHP in control and chronically epileptic tissue.</p> </sec> <sec id="epi12474-sec-0002" sec-type="section"> <title>Methods</title> <p>Using the rat pilocarpine model of chronic temporal lobe epilepsy, we performed whole‐cell patch‐clamp recordings of acutely isolated CA1 pyramidal cells and field potential measurements on hippocampal slices.</p> </sec> <sec id="epi12474-sec-0003" sec-type="section"> <title>Results</title> <p>Chronic oral administration of the CK2 inhibitor 4, 5, 6, 7‐tetrabromotriazole (TBB) for 4 days prior to brain dissection caused a significant increase of the sAHP‐mediating current in both control and epileptic tissues. In contrast, when TBB was acutely applied during the patch‐clamp recording, the sAHP remained unaltered, indicating that chronic CK2 inhibition was required for sAHP augmentation. To test whether CK2 inhibition also has an anticonvulsive effect, we evoked recurrent epileptiform discharges (REDs) in hippocampal slice preparations by<abstract abstract-type="main" id="epi12474-abs-0001"> <title>Summary</title> <sec id="epi12474-sec-0001" sec-type="section"> <title>Objective</title> <p>The slow afterhyperpolarizing potential (sAHP) following prolonged depolarization is a major intrinsic mechanism of neuronal inhibition, by powerfully dampening excitability for up to 2 s. Therefore, an altered sAHP function might be vulnerable to hyperexcitable states such as epilepsy. Here, we have investigated the role of casein kinase 2 (CK2) on the sAHP in control and chronically epileptic tissue.</p> </sec> <sec id="epi12474-sec-0002" sec-type="section"> <title>Methods</title> <p>Using the rat pilocarpine model of chronic temporal lobe epilepsy, we performed whole‐cell patch‐clamp recordings of acutely isolated CA1 pyramidal cells and field potential measurements on hippocampal slices.</p> </sec> <sec id="epi12474-sec-0003" sec-type="section"> <title>Results</title> <p>Chronic oral administration of the CK2 inhibitor 4, 5, 6, 7‐tetrabromotriazole (TBB) for 4 days prior to brain dissection caused a significant increase of the sAHP‐mediating current in both control and epileptic tissues. In contrast, when TBB was acutely applied during the patch‐clamp recording, the sAHP remained unaltered, indicating that chronic CK2 inhibition was required for sAHP augmentation. To test whether CK2 inhibition also has an anticonvulsive effect, we evoked recurrent epileptiform discharges (REDs) in hippocampal slice preparations by Mg<sup>2+</sup> removal. It is important to note that chronic oral TBB administration abolished REDs induced by 0‐Mg<sup>2+</sup> solution, suggesting that CK2 inhibition indeed has anticonvulsive and perhaps antiepileptogenic properties.</p> </sec> <sec id="epi12474-sec-0004" sec-type="section"> <title>Significance</title> <p>Our data demonstrated that CK2 inhibition augments the sAHP and might represent a novel mechanism of action of anticonvulsant drugs.</p> </sec> </abstract> … (more)
- Is Part Of:
- Epilepsia. Volume 55:Issue 1(2014:Jan.)
- Journal:
- Epilepsia
- Issue:
- Volume 55:Issue 1(2014:Jan.)
- Issue Display:
- Volume 55, Issue 1 (2014)
- Year:
- 2014
- Volume:
- 55
- Issue:
- 1
- Issue Sort Value:
- 2014-0055-0001-0000
- Page Start:
- 175
- Page End:
- 183
- Publication Date:
- 2013-12-06
- Subjects:
- Epilepsy -- Periodicals
616.853 - Journal URLs:
- http://www.blackwell-synergy.com/servlet/useragent?func=showIssues&code=epi ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1111/epi.12474 ↗
- Languages:
- English
- ISSNs:
- 0013-9580
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3793.700000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 3603.xml